Bcl-2 and mdr-1 gene expression during doxorubicin-induced apoptosis in murine leukemic P388 and P388/R84 cells

Cheppail Ramachandran, Wei You, Awtar Krishan

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The induction of apoptosis by doxorubicin (DOX) alone or in the presence of efflux blockers, verapamil (VPL) or trifluoperazine (TFP), and of bcl-2 and mdr-1 gene expression was analysed in murine leukaemic P388 and doxorubicin resistant P388/R84 cells. Incubation with DOX (0.1-1 μM) for 24 hours induced apoptosis in sensitive cells but not in the resistant P388/R84 cells. Flow cytometric analysis of apoptosis by terminal dideoxynucleotidyl (TdT) assay showed that 1 μM DOX induced apoptosis in 70% of P388 cells and in less than 5% of P388/R84 cells. When P388/R84 resistant cells were co-incubated with DOX and efflux blockers (10 μM VPL or 15 μM TFP), enhanced cellular DOX accumulation was accompanied by apoptosis. Quantitative analysis of DNA fragmentation by 14C-thymidine incorporation and gel electrophoresis of fragmented DNA confirmed the results from TdT assay and showed enhancement of DOX-induced DNA fragmentation in the presence of efflux blockers (VPL or TFP). DOX + VPL and DOX + TFP combination treatments induced apoptosis in upto 55% and 83% of P388/R84 cells, respectively. mdr-1 mRNA and P-gp expression were not altered during DOX-induced apoptosis. The results suggest that in murine leukemic cells, down-regulation of bcl-2 mRNA expression occurs during DOX-induced apoptosis and it depends on the cellular drug retention determined by mdr-1/P-gp drug efflux.

Original languageEnglish
Pages (from-to)3369-3376
Number of pages8
JournalAnticancer Research
Volume17
Issue number5 A
StatePublished - Sep 1 1997
Externally publishedYes

Fingerprint

Doxorubicin
Apoptosis
Gene Expression
Trifluoperazine
Verapamil
DNA Fragmentation
Messenger RNA
Pharmaceutical Preparations
Thymidine
Electrophoresis
Down-Regulation
Gels
DNA

Keywords

  • Apoptosis
  • bcl-2 and mdr-1
  • Doxorubicin
  • Drug resistance

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Bcl-2 and mdr-1 gene expression during doxorubicin-induced apoptosis in murine leukemic P388 and P388/R84 cells. / Ramachandran, Cheppail; You, Wei; Krishan, Awtar.

In: Anticancer Research, Vol. 17, No. 5 A, 01.09.1997, p. 3369-3376.

Research output: Contribution to journalArticle

Ramachandran, Cheppail ; You, Wei ; Krishan, Awtar. / Bcl-2 and mdr-1 gene expression during doxorubicin-induced apoptosis in murine leukemic P388 and P388/R84 cells. In: Anticancer Research. 1997 ; Vol. 17, No. 5 A. pp. 3369-3376.
@article{7dc8d194aff14d3b8ed028778fbbad91,
title = "Bcl-2 and mdr-1 gene expression during doxorubicin-induced apoptosis in murine leukemic P388 and P388/R84 cells",
abstract = "The induction of apoptosis by doxorubicin (DOX) alone or in the presence of efflux blockers, verapamil (VPL) or trifluoperazine (TFP), and of bcl-2 and mdr-1 gene expression was analysed in murine leukaemic P388 and doxorubicin resistant P388/R84 cells. Incubation with DOX (0.1-1 μM) for 24 hours induced apoptosis in sensitive cells but not in the resistant P388/R84 cells. Flow cytometric analysis of apoptosis by terminal dideoxynucleotidyl (TdT) assay showed that 1 μM DOX induced apoptosis in 70{\%} of P388 cells and in less than 5{\%} of P388/R84 cells. When P388/R84 resistant cells were co-incubated with DOX and efflux blockers (10 μM VPL or 15 μM TFP), enhanced cellular DOX accumulation was accompanied by apoptosis. Quantitative analysis of DNA fragmentation by 14C-thymidine incorporation and gel electrophoresis of fragmented DNA confirmed the results from TdT assay and showed enhancement of DOX-induced DNA fragmentation in the presence of efflux blockers (VPL or TFP). DOX + VPL and DOX + TFP combination treatments induced apoptosis in upto 55{\%} and 83{\%} of P388/R84 cells, respectively. mdr-1 mRNA and P-gp expression were not altered during DOX-induced apoptosis. The results suggest that in murine leukemic cells, down-regulation of bcl-2 mRNA expression occurs during DOX-induced apoptosis and it depends on the cellular drug retention determined by mdr-1/P-gp drug efflux.",
keywords = "Apoptosis, bcl-2 and mdr-1, Doxorubicin, Drug resistance",
author = "Cheppail Ramachandran and Wei You and Awtar Krishan",
year = "1997",
month = "9",
day = "1",
language = "English",
volume = "17",
pages = "3369--3376",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "5 A",

}

TY - JOUR

T1 - Bcl-2 and mdr-1 gene expression during doxorubicin-induced apoptosis in murine leukemic P388 and P388/R84 cells

AU - Ramachandran, Cheppail

AU - You, Wei

AU - Krishan, Awtar

PY - 1997/9/1

Y1 - 1997/9/1

N2 - The induction of apoptosis by doxorubicin (DOX) alone or in the presence of efflux blockers, verapamil (VPL) or trifluoperazine (TFP), and of bcl-2 and mdr-1 gene expression was analysed in murine leukaemic P388 and doxorubicin resistant P388/R84 cells. Incubation with DOX (0.1-1 μM) for 24 hours induced apoptosis in sensitive cells but not in the resistant P388/R84 cells. Flow cytometric analysis of apoptosis by terminal dideoxynucleotidyl (TdT) assay showed that 1 μM DOX induced apoptosis in 70% of P388 cells and in less than 5% of P388/R84 cells. When P388/R84 resistant cells were co-incubated with DOX and efflux blockers (10 μM VPL or 15 μM TFP), enhanced cellular DOX accumulation was accompanied by apoptosis. Quantitative analysis of DNA fragmentation by 14C-thymidine incorporation and gel electrophoresis of fragmented DNA confirmed the results from TdT assay and showed enhancement of DOX-induced DNA fragmentation in the presence of efflux blockers (VPL or TFP). DOX + VPL and DOX + TFP combination treatments induced apoptosis in upto 55% and 83% of P388/R84 cells, respectively. mdr-1 mRNA and P-gp expression were not altered during DOX-induced apoptosis. The results suggest that in murine leukemic cells, down-regulation of bcl-2 mRNA expression occurs during DOX-induced apoptosis and it depends on the cellular drug retention determined by mdr-1/P-gp drug efflux.

AB - The induction of apoptosis by doxorubicin (DOX) alone or in the presence of efflux blockers, verapamil (VPL) or trifluoperazine (TFP), and of bcl-2 and mdr-1 gene expression was analysed in murine leukaemic P388 and doxorubicin resistant P388/R84 cells. Incubation with DOX (0.1-1 μM) for 24 hours induced apoptosis in sensitive cells but not in the resistant P388/R84 cells. Flow cytometric analysis of apoptosis by terminal dideoxynucleotidyl (TdT) assay showed that 1 μM DOX induced apoptosis in 70% of P388 cells and in less than 5% of P388/R84 cells. When P388/R84 resistant cells were co-incubated with DOX and efflux blockers (10 μM VPL or 15 μM TFP), enhanced cellular DOX accumulation was accompanied by apoptosis. Quantitative analysis of DNA fragmentation by 14C-thymidine incorporation and gel electrophoresis of fragmented DNA confirmed the results from TdT assay and showed enhancement of DOX-induced DNA fragmentation in the presence of efflux blockers (VPL or TFP). DOX + VPL and DOX + TFP combination treatments induced apoptosis in upto 55% and 83% of P388/R84 cells, respectively. mdr-1 mRNA and P-gp expression were not altered during DOX-induced apoptosis. The results suggest that in murine leukemic cells, down-regulation of bcl-2 mRNA expression occurs during DOX-induced apoptosis and it depends on the cellular drug retention determined by mdr-1/P-gp drug efflux.

KW - Apoptosis

KW - bcl-2 and mdr-1

KW - Doxorubicin

KW - Drug resistance

UR - http://www.scopus.com/inward/record.url?scp=0030775164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030775164&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 3369

EP - 3376

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 5 A

ER -